2023-05-08 13:14:01 ET
- Mersana Therapeutics ( NASDAQ: MRSN ) is scheduled to announce Q1 earnings results on Tuesday, May 9th, before market open.
- The consensus EPS Estimate is -$0.48 (+18.6% Y/Y) and the consensus Revenue Estimate is $18.29M (+801.0% Y/Y).
- Over the last 1 year, MRSN has beaten EPS estimates 0% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 2 upward revisions and 0 downward. Revenue estimates have seen 2 upward revisions and 0 downward.
For further details see:
Mersana Therapeutics Q1 2023 Earnings Preview